Table 1. Characteristics of IBD patients (N = 646).
| Factors | CD N = 387 | UC N = 259 | P |
|---|---|---|---|
| Age, yrs[Median (range)] | 31(16-78) | 44(16-75) | <0.001 |
| Male [N (%)] | 260(67.2) | 152(58.7) | 0.028 |
| C. difficile positive [N (%)] (%)] | 49(12.7) | 50(19.3) | 0.022 |
| Bowel surgery [N (%)] | 103(26.6) | 12(4.6) | <0.001 |
| Medication use [N (%)] | |||
| Antibiotics | 99(25.6) | 120(26.3) | <0.001 |
| metronidazole | 44(11.4) | 98(37.8) | <0.001 |
| levofloxacin | 23(5.9) | 38(14.7) | <0.001 |
| cephalosporin | 70(18.1) | 39(15.1) | 0.314 |
| Systemic steroids | 162(41.9) | 131(50.6) | 0.029 |
| Oral 5-ASA | 190(49.1) | 243(93.8) | <0.001 |
| Immunosuppressant | 176(45.5) | 38(14.7) | <0.001 |
| Infliximab | 187(48.3) | 38(14.7) | <0.001 |
| PPI | 146(37.7) | 78(30.1) | 0.046 |
PPI, proton pump inhibitors.